Exact Sciences Corp (NASDAQ:EXAS) Director Daniel Levangie sells 5,000 shares on March 1, 2024. The transaction was executed at a price of $57.5 per share, resulting in a total sale amount of $287,500. Exact Technologies Corp is a molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer.